Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma
Open Access
- 25 April 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (28) , 45784-45792
Abstract
Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinomaKeywords
This publication has 32 references indexed in Scilit:
- Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumorsCancer Genetics, 2016
- Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profilesThe Journal of Pathology, 2016
- TERT promoter mutations in thyroid cancerEndocrine-Related Cancer, 2016
- Thyroid Gland MalignanciesHematology/Oncology Clinics of North America, 2015
- BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysisEndocrine-Related Cancer, 2015
- Integrated Genomic Characterization of Papillary Thyroid CarcinomaCell, 2014
- Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assayCancer, 2014
- Oncogenic gene fusions in epithelial carcinomasCurrent Opinion in Genetics & Development, 2009
- The impact of translocations and gene fusions on cancer causationNature Reviews Cancer, 2007
- A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995Cancer, 1998